Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coronary Drug Project Mortality Surveillance
NCT00000483Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 1981
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of conjugated estrogens, clofibride, dextrothyroxine and niacin in myocardial infarction (MI) and coronary heart disease (CHD) (6 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Total Mortality at 15 years. Started Jun 1981; status: completed.
02
Drugs
conjugated estrogensclofibridedextrothyroxineniacin
03
Conditions
myocardial infarction (MI)coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00000483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000483.